Partial operating KPIs
This page has 3 company-specific operating KPI charts. A sourced floor is 4. Sector membership does not count.
Fourier Intelligence Cumulative Disclosed Funding (Estimate)
Cumulative raised ($M)
Fourier Intelligence Funding Rounds (Estimate)
| Round (date, lead) | Amount ($M) | Post-Money ($M) |
|---|---|---|
| Series A (2018-02, IDG Capital) | 10 | |
| Series B/C (2019-2021, Saudi Prosperity7 + IDG) | ||
| Series D (2022-01, SoftBank Vision Fund II + Yuanjing) | 63 | |
| Series E (2025-01, Guoxin + Pudong VC + Prosperity7) | 109 |
Fourier Intelligence: GR-Series Humanoids + Rehabilitation Robotics Bi-Modal Business
| Date / Milestone | Business Line | Detail |
|---|---|---|
| 2015. Fourier Intelligence founded | Rehabilitation robotics | Alex Gu starts the company; first upper-limb rehabilitation robot released in 2016 and first lower-limb exoskeleton, X1, in 2017 |
| 2017-2020. Rehab product line expansion | Rehabilitation | ExoMotus M4 (lower-limb) + Maximo M4 (variant) + ArmMotus EMU (upper-limb) + RehabHub IoT platform; expansion to international markets |
| 2020-2022. ~2,000+ hospitals + rehab centers in 50+ countries | Rehabilitation | Cumulative installed base; primary revenue source; profitable line by ~2022 |
| 2023-07. GR-1 humanoid unveiled at WAIC Shanghai | GR-series humanoid (industrial) | First Fourier humanoid; 165 cm; about 52 kg; FSA actuators; up to 44 DoF; not commercially deployed in 2023 |
| 2024-04. GR-1 commercial pilots | GR-1 | Limited commercial pilots in industrial + research applications; cumulative ~50 units shipped through 2024 |
| 2024-09. GR-2 unveiled | GR-2 | 53 body DoF; 12 DoF per hand with 6 array-type tactile sensors per hand; 2-hour quick-swap battery; targets industrial logistics + research |
| 2025-01-07. Series E $109M led by domestic consortium ($1.1B post-money) | Both lines | Series E ~RMB 800M / ~$109M led by Guoxin Investment + Pudong Venture Capital + Prosperity7; SoftBank Vision Fund had earlier led the Series D (RMB 400M / ~$54.7M); targets GR-series scale-up + international rehab expansion |
| 2025-Q2. GR-2 industrial pilots announced | GR-2 | Chinese auto OEM pilot (BYD or Geely; industry reports differ); Japanese research-institution pilot; targets ~200 GR-2 units shipped 2025 |
| 2025-Q4. RehabHub IoT platform expanded | Rehabilitation | Cloud-connected rehab platform expansion; integrates AI-driven exercise programming; Fourier characterizes as 'precursor to AI-enabled humanoid rehab caregivers' |
| Editorial. Bi-modal economics question | Strategic context | Fourier reportedly generates ~$100M+ annual rehab revenue (private, not audited) with mid-teens gross margins. GR-series industrial humanoids are R&D + customer-pilot-stage with effectively no commercial revenue through 2025. The cross-subsidy lets Fourier sustain GR-series investment longer than pure-play industrial competitors at the same funding stage. The SoftBank-led Series D was the inflection point where outside capital meaningfully accelerated GR-series development independent of rehab cash flow |

Fourier Intelligence in Humanoid Robots
KPI data tables
Fourier Intelligence operating metrics behind the KPI charts, newest period first (up to 24 periods per chart). Periods use each company's own fiscal labels where the source does; each table names its source.
| Period | Cumulative raised ($M) |
|---|---|
| 2025-01 Series E | 182 |
| 2022-01 Series D | 73 |
| 2018-02 Series A | 10 |
Source: src/data/kpis/fourier-intelligence/funding-rounds.json